Showing 1–50 of 54 results
-
Research | | Open
-
Research | | Open
-
Research | | Open
-
Research | | Open
-
Correspondence | | Open
-
Research | | Open
-
Research | | Open
-
Research |
-
-
Research |
-
Research |
-
-
-
Research |
-
Research |
-
Research |
-
Research |
-
Research |
-
Research |
-
Research |
-
| Open
-
-
Research |
-
Research |
-
Reviews | | Open
-
Research |
-
| Open
Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: a phase II study of the Spanish GOTI group
- P Garcia-Alfonso
- , A Muñoz-Martin
- , M Mendez-Ureña
- , R Quiben-Pereira
- , E Gonzalez-Flores
- & G Perez-Manga
British Journal of Cancer 101 , 1039–1043 -
-
Research |
-
Research |
-
Research |
-
-
Research | | Open
-
Research | | Open
-
Research |
-
Research | | Open
-
Research | | Open
-
Research |
-
Research | | Open
-
Research |
-
Research |
-
Research |
-
Research |
-
Research | | Open
-
Research |
-
Research |
-
Research |
-
Research | | Open
-
Research |
-
Research |